A team of Canadian researchers led by a neurologist has made a breakthrough discovery which could play an essential role in the creation of future treatments for Alzheimer’s disease.
The team performed several tests on mice which received treatment in the form of injections with specific strings of amino acids. The results infer that the treatment was able to improve the memory of the animals while also mitigating some of the physical changes which are associated with the evolution of the disease in the long run.
According to the lead researcher, the result is quite essential since it shows that besides improving the memory of the mice, the drug was also able to alter the pathology of the brain, generating positive results. Alzheimer’s is a well-known disease, affecting millions of patients spread across all over the world. It is classified as a type of dementia which can compromise memory, thinking, and behavior. Most symptoms will tend to appear slowly in time, and they tend to become worse as the years pass.
New Details On Alzheimer’s Disease Revealed Thanks To New Research
According to official statistics, Alzheimer’s is one of the most common causes of dementia, an umbrella term which covers a variety of symptoms, among which we can count memory loss and the appearance of several cognitive issues.
Getting older is the primary factor which contributes to the appearance of Alzheimer’s as most patients are 65 or older. In some cases, it is also identified among younger patients, and this form is known as early-onset Alzheimer’s.
Since the disease is progressive, the symptoms will become worse in time. During the early stages of the disease memory loss is mild but during the late phase, many patients will lose the ability to talk with other people or be aware of the environment which surrounds them. The team is working on an oral version of the drug, and human trials could begin in a few years.